NYLIM Candriam U.S. Mid Cap Equity ETF
IQSMNYSEARCANYLIMEquity
As of Oct 15, 2026 close
- Assets (AUM)
- $358.84M
- Expense ratio
- 0.15%
- Dividend yield
- 1.06%
- Holdings
- 247
- 52-week range
- $32.77$40.88
- Volume (live)
- -
- Avg. volume (3M)
- 34.36K
IQSM ETF: NYLIM Candriam U.S. Mid Cap Equity ETF - Price, Holdings & Analysis
NYLIM Candriam U.S. Mid Cap Equity ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $38.81 - $38.81 |
|---|---|
| 52-Week High | $40.88 |
| 52-Week Low | $32.77 |
| Open | $38.81 |
| Volume (last close) | 300.89K |
| Average Volume (3M) | 34.36K |
| 1 Day Change | +1.50% |
|---|---|
| 1 Month Change | −0.61% |
| 6 Month Change | +5.70% |
| YTD Change | +10.95% |
| 1 Year Change | +15.48% |
| Annual Dividend | $0.41 |
|---|---|
| Dividend Yield | 1.06% |
| Last Dividend Ex-Date | Sep 18, 2026 |
| Dividend Growth YoY | −0.81% |
| Years Dividend Growth | 3 |
| Assets (AUM) | $358.84M |
|---|---|
| Expense Ratio | 0.15% |
| Total Holdings | 247 |
| Inception Date | Oct 24, 2022 |
| 50-Day MA | $39.68 |
|---|---|
| 200-Day MA | $37.75 |
| RSI | 36.73 |
| Stochastic %K | 0.34 |
| Stochastic %D | 20.95 |
Source: Exchange price data and fund disclosures. Data as of Oct 15, 2026. Data sources and methodology
IQSM at a Glance
NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) is an equity ETF from NYLIM, launched in October 2022. It manages $358.84M in assets and charges a 0.15% expense ratio, about $15 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 247 positions. The largest are Moderna, Inc (MRNA, 1.97%), Revolution Medicines, Inc (RVMD, 1.45%) and Twilio Inc (TWLO, 1.15%). The top 10 holdings make up 10.9% of the fund. By sector it leans toward Technology (19.6%), Industrials (18.6%) and Healthcare (16.2%). 97.3% of assets are in the United States.
It pays distributions yielding 1.06% at the Oct 15, 2026 close, $0.41 per share over the trailing 12 months. As of the Oct 15, 2026 close, the share price is up 15.5% over one year (price change, excluding distributions).
Frequently Asked Questions About NYLIM Candriam U.S. Mid Cap Equity ETF
What is the current price of IQSM?
The latest IQSM price is $38.81 (Oct 15, 2026 close). The 52-week range is $32.77–$40.88. The share price is up 15.5% over the past year (price change, excluding distributions).
What is the expense ratio for IQSM?
IQSM's annual expense ratio is 0.15%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does IQSM pay dividends?
Yes, IQSM pays a 1.06% dividend yield (trailing 12 months, at the Oct 15, 2026 close). The most recent ex-dividend date was September 18, 2026. View full dividend history in the Dividends section.
What are the top holdings of IQSM?
As of Oct 4, 2026, IQSM's largest holdings are Moderna, Inc (2.0%), Revolution Medicines, Inc (1.5%), Twilio Inc (1.2%) (combined weight: 4.6%). The fund holds 247 total positions. View the complete portfolio breakdown in the Holdings section.
How does IQSM compare to similar ETFs?
Compare IQSM (0.15% expense ratio, $359M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.